0051: Cost-Effectiveness Analysis of Treatment Paradigms for Stage I and II Endometrial Cancer

J. Kim , J. S. Kwon , M. S. Carey , S. Goldie
International Journal of Gynecologic Cancer 16

2006
O361 Cost-effectiveness of alternative strategies for first-trimester abortion in Mexico and Nigeria

D. Hu , D. Grossman , C. Levin , K. Blanchard
International Journal of Gynecology & Obstetrics 107 S195 -S195

2009
Cytomegalovirus as a Primary Pulmonary Pathogen in AIDS

Aaron B. Waxman , Richard A. Matthay , Susanne J. Goldie , Helena Brett-Smith
Chest 111 ( 1) 128 -134

46
1997
Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United States.

DAVID N. FISMAN , MARC LIPSITCH , EDWARD W. HOOK , SUE J. GOLDIE
Sexually Transmitted Diseases 29 ( 10) 608 -622

45
2002
A refined estimate of the average lifetime cost of pelvic inflammatory disease.

JENNIFER M. YEH , EDWARD W. HOOK , SUE J. GOLDIE
Sexually Transmitted Diseases 30 ( 5) 369 -378

91
2003
Scaling Up Antiretroviral Therapy in South Africa: The Impact of Speed on Survival

Rochelle P. Walensky , Robin Wood , Milton C. Weinstein , Neil A. Martinson
The Journal of Infectious Diseases 197 ( 9) 1324 -1332

70
2008
A Monte Carlo Simulation of Advanced HIV Disease

A DAVID PALTIEL , JULIE A SCHARFSTEIN , GEORGE R SEAGE , DSc Ill

19
2004
Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications

Sue J Goldie , Meredith O’Shea , Mireia Diaz , Sun-Young Kim
Reproductive Health Matters 16 ( 32) 86 -96

74
2008
Health and economic impact of rotavirus vaccination in GAVI-eligible countries

Sun-Young Kim , Steve Sweet , David Slichter , Sue J Goldie
BMC Public Health 10 ( 1) 253 -253

43
2010
Salud global 2035: un mundo convergiendo en el lapso de una generación

Dean T Jamison , George Alleyne , Kenneth J Arrow , Seth Berkley
Salud Publica De Mexico 57 ( 5) 444 -467

8
2015
Alma-Ata at 40 years: reflections from the Lancet Commission on Investing in Health.

David A Watkins , Gavin Yamey , Marco Schäferhoff , Olusoji Adeyi
The Lancet 392 ( 10156) 1434 -1460

41
2018
Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts

Yazdan Yazdanpanah , Geneviève Chêne , Elena Losina , Sue J Goldie
International Journal of Epidemiology 30 ( 4) 864 -871

57
2001
National and sub-national analysis of the health benefits and cost-effectiveness of strategies to reduce maternal mortality in Afghanistan.

Natalie Carvalho , Ahmad Shah Salehi , Sue J Goldie
Health Policy and Planning 28 ( 1) 62 -74

25
2013
The effectiveness of yoga in modifying risk factors for cardiovascular disease and metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials:

Paula Chu , Rinske A Gotink , Gloria Y Yeh , Sue J Goldie
European Journal of Preventive Cardiology 23 ( 3) 291 -307

99
2016
Cost-effectiveness of Rotavirus vaccination in Vietnam

Sun-Young Kim , Sue J Goldie , Joshua A Salomon ,
BMC Public Health 9 ( 1) 29 -29

53
2009
Are European-specific guidelines needed for prevention of opportunistic infections in HIV-1?

Yazdan Yazdanpanah , Sue J Goldie , Roger Salamon , Yves Mouton
The Lancet 354 ( 9186) 1305 -1306

3
1999
[Global health 2035: a world converging within a generation].

Dean T Jamison , Lawrence H Summers , George Alleyne , Kenneth J Arrow
The Lancet 382 ( 9908) 1898 -1955

1,461
2013